The sudden death of a Northern Arizona resident due to the pneumonic plague- a diseases that is the known cause of the century old health crisis bubonic plague, has raised alarm among the locals and health officials alike. The person died from the plague just 24 hours after feeling sick and showing symptoms. This is a rare but serious case of the disease in the United States amid the declining rate of immunization. The person, whose name hasn't been released, was taken to Flagstaff Medical Center in a very bad condition and passed away the same day.

The case has raised new worries, especially since it happened at the same time as many prairie dogs were reported dying near Flagstaff. This is a natural warning sign that the plague might be spreading among wild animals in the area.

What Is Pneumonic Plague?

Plague is a rare but serious illness that can affect both animals and humans. It's caused by a type of bacteria called Yersinia pestis (Y. pestis). These bacteria are found in wild rodents and their fleas in many parts of the world, including most of the western United States. Pneumonic Plague is a more concerning type because it affects the lungs. It happens when you breathe in the Y. pestis bacteria. This form of plague can be spread from person to person. Symptoms of pneumonic plague usually start one to four days after exposure. These include:

• Fever
• Headache
• Weakness
• A cough that produces bloody or watery mucus (due to lung infection, or pneumonia)

If you start showing symptoms, see a doctor right away. If you think you might have been intentionally exposed to pneumonic plague, contact law enforcement immediately. Currently, there's no vaccine for pneumonic plague. However, antibiotics can be used to prevent illness in people who have been exposed to the bacteria.

How Are Prairie Dogs Linked To This?

According to a report received by Coconino County Health and Human Services (CCHHS) on 7th July, Townsend Winona area experienced a prairie dog die-off. They explained that a sudden die-off of prairie dogs and other rodents can be a warning sign for plague, a serious disease that can affect both animals and people. The bacteria that cause plague, Yersinia pestis, spread through the bite of infected fleas or by touching sick animals. People can also get infected from sick pets.

Can The Plague Be Prevented?

The affected area is on private land, CCHHS is working with the property owner to collect fleas for testing. They'll also contact other nearby property owners to expand their checks and potentially treat the area. Rodent burrows will be treated to reduce flea activity, and the area will continue to be watched closely because plague is common in Coconino County, CCHHS has a system to monitor for the disease. They also watch for other diseases like West Nile virus and rabies to quickly find them, understand how they spread, and take steps to protect the public. Here are some preventative tips you should have

Protect your pets from fleas

Use veterinarian-approved flea treatments, keep your pets on a leash, and keep them away from areas where wild rodents live.

Report dead rodents

If you see many dead rodents or rabbits, please call animal services

Keep rodents away from your home

Clear away brush, rock piles, trash, and lumber from around your house and sheds. Store food in containers that rodents can't get into.

Avoid wild animals

Never feed or touch wild rodents, and stay away from areas where they are known to live. Do not touch sick or dead animals.

Prevent flea bites

Use insect repellent with 20-30% DEET and tuck your pant legs into your socks.

Keep dogs on leash

This prevents them from roaming around rodent burrows and is also required by Arizona State law.

Be careful when camping

Don't camp near rodent burrows and avoid sleeping directly on the ground.

Be aware of sick cats

Cats can easily get plague. If your cat is sick (especially if it roams outside), take it to a vet right away for diagnosis and treatment to reduce the risk of people getting plague.

Get vet care for sick pets

If your pet shows symptoms like a high fever, swollen lymph nodes, tiredness, loss of appetite, a cough, or eye discharge, contact a veterinarian immediately.

Over 1 in 100 people worldwide living with celiac disease, consuming even trace amounts of gluten can trigger debilitating symptoms — from severe abdominal pain to long-term complications like malnutrition and increased cancer risk. But despite decades of research, the exact origin of these immune reactions remained something of a mystery.

Now, scientists may have pinpointed the elusive starting point of gluten-triggered immune attacks. In a landmark study published in Gastroenterology, researchers from McMaster University in Canada, along with international collaborators, have uncovered a pivotal role played by the cells lining the gut — not just as bystanders but as active agents in the cascade that defines celiac disease. This finding could pave the way for more precise, non-dietary therapies.

Celiac disease is a chronic autoimmune condition triggered by gluten — a group of structural proteins found in wheat, barley, and rye. While most people digest gluten without issue, those with celiac disease experience an abnormal immune reaction that damages the small intestine.

The symptoms range from bloating, abdominal pain, and diarrhea to fatigue, skin rashes, and nutrient deficiencies. Over time, untreated celiac disease can lead to serious complications including osteoporosis, infertility, and gastrointestinal cancers.

Currently, the only effective treatment is lifelong strict avoidance of gluten — a tall order, given how ubiquitous gluten is in processed food, sauces, and even medications.

One clue to the mystery lies in genetics. Nearly 90% of people with celiac disease carry a specific protein called HLA-DQ2.5, while most of the rest carry HLA-DQ8. These proteins are part of a group called human leukocyte antigens (HLAs), which present bits of proteins to the immune system — essentially acting like flags that identify threats.

In people with celiac disease, HLA-DQ2.5 or DQ8 mistakenly flags gluten fragments as dangerous, prompting an aggressive immune response. But not everyone who carries these genes gets the disease — suggesting something else is required to flip the switch.

Link Between Your Gut Cells and Gluten

Until now, it wasn’t fully understood how gluten peptides made their way past the gut lining and into the immune system’s crosshairs. The McMaster-led study changes that.

By using transgenic mice — mice genetically engineered to carry human versions of the HLA genes — researchers were able to simulate celiac disease at the cellular level. They grew miniature gut models known as organoids, made from real mouse intestinal cells, to observe what happens when gluten meets the gut lining.

What they found was striking: the epithelial cells lining the gut aren’t passive observers — they actively participate in the immune reaction.

These cells release a transporting enzyme that binds to gluten peptides and modifies them, making them even more visible to the immune system. The cells then present these altered gluten fragments directly to immune cells, triggering inflammation.

In other words, your own gut lining might be the place where celiac disease begins.

Gut Microbes Could Be Amplifying the Problem

Another major insight: inflammation and gut microbes appear to amplify the immune response. When the researchers exposed their organoids to inflammatory triggers and bacteria-processed gluten, the cells ramped up production of immune signaling molecules — effectively supercharging the immune reaction.

This discovery opens new avenues for treatment. Targeting the gut’s microbiome or blocking the epithelial cells’ presentation of gluten peptides could offer alternatives to the gluten-free diet — something patients and clinicians alike have long hoped for.

Lead researcher Dr. Elena Verdu, a gastroenterologist at McMaster, notes that while avoiding gluten is currently the only way to manage celiac disease, it is far from perfect.

“This is difficult to do, and experts agree that a gluten-free diet is insufficient,” Verdu says. “Our findings show that the gut lining plays a much bigger role in initiating the immune reaction than previously believed.”

By identifying the specific tissue types and enzymes involved, scientists now have a roadmap for developing targeted treatments. In the future, medications might block the gut’s gluten-presenting function, regulate inflammation, or even alter how gut bacteria break down gluten — all without having to eliminate gluten entirely.

Can This Help End the Gluten-Free Dietary Restrictions?

This breakthrough adds weight to the growing understanding that celiac disease is not just about the immune system being “overreactive,” but about how and where that reaction begins.

Tohid Didar, a biomedical engineer on the team, says, “This allowed us to narrow down the specific cause and effect and prove exactly whether and how the reaction takes place.”

Such clarity has never existed before. Now, with this map in hand, researchers can explore new therapies that go beyond dietary restrictions. Of course, these results — while promising — are still early. Most of the experiments were conducted on mice, though they carry human genes. The next step will be to confirm these findings in human tissue and clinical trials.

But the implications are clear: for the first time, we know where gluten reactions start. And we might soon have a path to stop them.

For people living with celiac disease, even a crumb of gluten can cause days of pain and damage. This research brings us one step closer to a world where bread, pasta, and pastries can be safely enjoyed — without fear and without compromise.

It’s easy to blame low libido on stress, hormones, or simple fatigue but what if the actual perpetrator lurks deeper—literally? More and more, studies are indicating your gut health as a main player in affecting sexual desire.

The gut is no longer seen as merely a digestive system. It's today understood to be a command center for a broad range of body functions—immunity, hormone balance, and even emotional well-being. And all of them have a direct or indirect impact on libido.

At the core of this connection is the gut-brain axis, a two-way communication pathway linking your gastrointestinal system with your central nervous system. This process enables your gut microbiome to impact major brain chemicals such as serotonin and dopamine, both of which are important in mood, motivation, and arousal. This is the thing: roughly 90% of the body's serotonin is actually made in the gut. So when your gut is out of whack, your mood, energy, and sex drive can suffer.

What is Estrobolome?

One of the most interesting new finds is the estrobolome—a special group of gut bacteria that break down estrogen. The bacteria secrete an enzyme called β-glucuronidase, which recycles estrogen and keeps hormones in check.

When the estrobolome gets disturbed—perhaps by a bad diet, stress, or antibiotics—it can disrupt estrogen balance. What's the consequence? Mood swings, PMS, exhaustion, and a vanishing libido.

Why Your Gut Might Be Draining Your Energy?

Even when you're eating all the right foods, a gut that doesn't work well can interfere with your ability to take in necessary nutrients such as iron, vitamin B12, and magnesium—all of which play a central role in energy and mood management. Without sufficient supplies of these, you might feel perpetually drained and mentally cloudy. And let's face it—nobody feels sexy if they're not rested.

Add to that chronic inflammation and disrupted neurotransmitter production, and you’ve got a recipe for low libido that can’t be fixed by aphrodisiacs alone.

How Your Gut Affecting Your Sex Life?

If you're consistently experiencing bloating, constipation, or IBS-type symptoms and also experiencing poor sleep, mood swings, or irregular periods, your gut is likely playing a more significant role than you realize. These overlapping symptoms indicate that your digestive system might be playing with your hormones and mood—both integral components of a healthy sex drive.

Gut health is no silver bullet, but it is an oft-overlooked part of the libido equation. Though great gut health will not necessarily trigger an increase in sexual appetite, it provides the groundwork for enhanced mood, vitality, and emotional preparedness—all prime motivators of a healthy libido.

As psychologists and nutrition scientists frequently point out, sexual desire is seldom purely biological. It's impacted by emotional attachment, self-esteem, satisfaction with one's relationship, stress levels, and even cultural conditioning.

How to Reset Your Gut and Revive Your Libido?

It's not difficult to enhance gut health, but it does need to be a habitual practice. Following are practical, science-supported methods to get your gut—and your libido—going strong:

Nourish your gut flora: Consume more whole foods containing fiber such as leafy greens, lentils, and whole grains.

Include fermented foods: Yogurt, kefir, sauerkraut, and kimchi add good bacteria.

Exercise regularly: Activity supports diversity of gut flora and reduces inflammation.

Deal with stress: Ongoing stress can disrupt the gut-brain axis. Try breathwork or mindfulness.

Sleep: Inadequate sleep disturbs both gut and hormonal balance.

Hydrate: Water keeps the gut mucosal lining intact, facilitating absorption and immunity.

Stay away from unnecessary antibiotics: They destroy both bad and good bacteria.

Your gut may be doing more than break down your food. It may be quietly influencing your mood, your hormones—and yes, your sex life. Although low libido can have countless causes, focusing on your gut is one of the most compelling ways to support your overall health and rediscover your desire. If you've been feeling "off," begin by paying attention to your gut. It might be attempting to communicate more with you than you realize.

A 57-year-old schoolteacher from Kolkata, Ruma Sen* had spent decades standing in front of classrooms, guiding young minds with poise and patience. But when her own body began to send quiet warnings—persistent bloating, fatigue that lingered, clothes fitting tighter than usual—she brushed it off. “I just assumed it was something I ate or part of aging,” she recalls. Yet, deep down, a quiet concern stirred. And then came the ultrasound that changed everything.

A mass on her left ovary. Fluid accumulating in her abdomen. The CT scan and biopsy confirmed what no one wants to hear: Stage IV high-grade serous ovarian cancer, with metastases to her intestines and abdominal lining.

“I felt like the floor had vanished beneath my feet,” Ruma says. “In that moment, the future I imagined just disappeared.”

“Ovarian cancer often whispers until it roars,” explained Dr. Debapriya Mondal, Ruma’s medical oncologist at Apollo Cancer Centre, Kolkata. “By the time it's diagnosed, it's usually advanced. But even Stage IV isn't without hope.”

This late-stage diagnosis is common with ovarian cancer, especially its most aggressive subtype—high-grade serous carcinoma. It lacks early symptoms that are easily distinguishable from benign issues like indigestion or menstrual irregularities. That’s why it’s dubbed the “silent killer.”

Round One: Chemotherapy as the First Line of Defense

Chemotherapy began within days of diagnosis. The plan was clear: shrink the tumors to make surgery safer and more effective. The process, however, was anything but clinical for Ruma.

“The first cycle made me violently nauseous. My hair fell out in clumps. I was too weak to stand some mornings,” she remembers. Despite the toll, the treatment was working. By the third cycle, imaging showed significant tumor shrinkage.

“Chemotherapy is brutal,” Dr. Mondal admits. “But when the scans show tumors shrinking, it’s our signal that we’re fighting back—and winning ground.”

Round Two: A Critical Turning Point Surgery

Ruma’s next hurdle was interval debulking surgery, a complex procedure to remove all visible tumors, followed by HIPEC (Hyperthermic Intraperitoneal Chemotherapy)—a method where heated chemotherapy is delivered directly into the abdominal cavity during surgery.

“It was the toughest part,” Ruma says. “I woke up in ICU with tubes everywhere. My abdomen felt like it was on fire.” Recovery was grueling. Ten days in the hospital marked by small but vital victories: sipping water, standing unaided, breathing without assistance.

“HIPEC is not for every patient,” Dr. Mondal says. “But in selected cases like Ruma’s, it increases the chances of a long remission or even a cure.”

Round Three: Genetic Testing and Personalized Medicine

As Ruma regained strength, her care team ordered homologous recombination deficiency (HRD) testing, a genomic analysis that helps determine how well a tumor repairs its DNA. The results revealed a germline BRCA1 mutation, a known genetic driver of ovarian cancer.

“This changed everything,” Dr. Mondal explains. “When tumors carry this mutation, we can use targeted maintenance therapy, such as PARP inhibitors, which drastically reduce the risk of recurrence.”

For Ruma, the discovery was both empowering and alarming. “I now had a new weapon against my cancer. But I also worried about what it meant for my daughters.”

She completed three more cycles of chemotherapy and transitioned to oral PARP inhibitors—medications designed to exploit her cancer’s genetic vulnerabilities. For the next two years, she remained under strict oncologic surveillance, with regular scans and bloodwork to track any signs of recurrence.

Ruma’s diagnosis didn’t just change her life—it changed her family’s trajectory.

Her two daughters, Megha** and Ananya**, underwent genetic counseling and testing. Megha, the elder at 35, tested positive for the same BRCA1 mutation. “It was a gut punch,” Megha says. “But I felt lucky to know.”

After consulting with specialists, she opted for risk-reducing salpingo-oophorectomy (RRSO)—a preventive surgery to remove her ovaries and fallopian tubes. “It meant early menopause. But it also meant I was taking control of my future,” Megha explains.

According to Dr. Mondal, this kind of cascade testing—where family members of patients with genetic mutations are screened—is vital. “We now have tools not just to treat cancer, but to prevent it. Megha’s decision may have significantly lowered her lifetime risk of ovarian and breast cancer.”

Today, Ruma is in clinical remission. She has resumed teaching, started leading yoga sessions for cancer survivors, and advocates for genetic testing and early detection. “I used to fear my body,” she admits. “Now I listen to it. I take care of it.”

She also speaks publicly about her cancer journey, helping dismantle the stigma and fear surrounding a disease that affects nearly 300,000 women worldwide each year, according to the World Health Organization.

“We are in a new era of precision oncology,” Dr. Mondal emphasizes. “We are no longer limited to one-size-fits-all treatments. Every tumor has a story written in its DNA—and we’re learning how to read it.”

Why It Is Important To Listen to Your Body?

Ruma’s story is more than a personal victory. It’s a real-world example of how modern oncology is evolving—from late diagnosis to targeted intervention, from suffering in silence to survivorship with purpose. Here’s what it tells us:

• Listen to your body, even when the symptoms seem minor.
• Early diagnosis remains rare, but genetic insights can improve long-term outcomes.
• Precision medicine—like HRD testing and PARP inhibitors—is rewriting how we approach advanced cancer.
• Genetic counseling empowers entire families, not just patients.
• And most importantly, survival is possible, even in Stage IV.

“I don’t know what the future holds,” Ruma says. “But I know I’ve done everything in my power to live it fully.”

Disclaimer: This article is based on a real-life medical journey. To protect the privacy of the individual and her family, names and identifying details have been changed. Medical information shared is for educational and awareness purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.